These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30061606)

  • 1. Inhibition of glycosphingolipid synthesis reverses skin inflammation and hair loss in ApoE-/- mice fed western diet.
    Bedja D; Yan W; Lad V; Iocco D; Sivakumar N; Bandaru VVR; Chatterjee S
    Sci Rep; 2018 Jul; 8(1):11463. PubMed ID: 30061606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/- mice and rabbits fed a high-fat and -cholesterol diet.
    Chatterjee S; Bedja D; Mishra S; Amuzie C; Avolio A; Kass DA; Berkowitz D; Renehan M
    Circulation; 2014 Jun; 129(23):2403-13. PubMed ID: 24710030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.
    Mishra S; Bedja D; Amuzie C; Avolio A; Chatterjee S
    Biochem Biophys Res Commun; 2015 Sep; 465(1):159-64. PubMed ID: 26253472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myriocin and d-PDMP ameliorate atherosclerosis in ApoE-/- mice via reducing lipid uptake and vascular inflammation.
    Yu Z; Peng Q; Li S; Hao H; Deng J; Meng L; Shen Z; Yu W; Nan D; Bai Y; Huang Y
    Clin Sci (Lond); 2020 Mar; 134(5):439-458. PubMed ID: 32091078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor.
    Mishra S; Bedja D; Amuzie C; Foss CA; Pomper MG; Bhattacharya R; Yarema KJ; Chatterjee S
    Biomaterials; 2015 Sep; 64():125-135. PubMed ID: 26111596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ganglioside biosynthesis and neurite outgrowth of primary cultured neurons by L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol.
    Usuki S; Hamanoue M; Kohsaka S; Inokuchi J
    J Neurochem; 1996 Nov; 67(5):1821-30. PubMed ID: 8863486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the action of ceramide-like substances (D- and L-PDMP) on sphingolipid glycosyltransferases and purified lactosylceramide synthase.
    Chatterjee S; Cleveland T; Shi WY; Inokuchi J; Radin NS
    Glycoconj J; 1996 Jun; 13(3):481-6. PubMed ID: 8781979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glycosphingolipid synthesis by threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and the modulation of IL-1beta-stimulated expression of inducible nitric oxide synthase in rat aortic smooth muscle cells.
    Weber AA; Seul C; Harth V; Ko Y; Seewald S; Vetter H; Sachinidis A
    Br J Pharmacol; 1998 Mar; 123(5):906-10. PubMed ID: 9535019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactosylceramide synthase β-1,4-GalT-V: A novel target for the diagnosis and therapy of human colorectal cancer.
    Chatterjee SB; Hou J; Bandaru VVR; Pezhouh MK; Syed Rifat Mannan AA; Sharma R
    Biochem Biophys Res Commun; 2019 Jan; 508(2):380-386. PubMed ID: 30502090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of glycosphingolipid biosynthesis by L-threo-1-phenyl-2-decanoylamino-1-propanol and its homologs in B16 melanoma cells.
    Inokuchi J; Usuki S; Jimbo M
    J Biochem; 1995 Apr; 117(4):766-73. PubMed ID: 7592537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipids in atherosclerosis and vascular biology.
    Chatterjee S
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1523-33. PubMed ID: 9763522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol alters cellular cholesterol homeostasis by modulating the endosome lipid domains.
    Makino A; Ishii K; Murate M; Hayakawa T; Suzuki Y; Suzuki M; Ito K; Fujisawa T; Matsuo H; Ishitsuka R; Kobayashi T
    Biochemistry; 2006 Apr; 45(14):4530-41. PubMed ID: 16584188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases.
    Pannu R; Won JS; Khan M; Singh AK; Singh I
    J Neurosci; 2004 Jun; 24(26):5942-54. PubMed ID: 15229242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an inhibitor of glucosylceramide synthase on glycosphingolipid synthesis and neurite outgrowth in murine neuroblastoma cell lines.
    Uemura K; Sugiyama E; Taketomi T
    J Biochem; 1991 Jul; 110(1):96-102. PubMed ID: 1834639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis.
    Felding-Habermann B; Igarashi Y; Fenderson BA; Park LS; Radin NS; Inokuchi J; Strassmann G; Handa K; Hakomori S
    Biochemistry; 1990 Jul; 29(26):6314-22. PubMed ID: 2207076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a glycolipid inhibitor to ameliorate renal cancer in a mouse model.
    Chatterjee S; Alsaeedi N; Hou J; Bandaru VV; Wu L; Halushka MK; Pili R; Ndikuyeze G; Haughey NJ
    PLoS One; 2013; 8(5):e63726. PubMed ID: 23671696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agents for the treatment of glycosphingolipid storage disorders.
    Abe A; Wild SR; Lee WL; Shayman JA
    Curr Drug Metab; 2001 Sep; 2(3):331-8. PubMed ID: 11513334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Modulation of Glycosphingolipid Metabolism.
    Inokuchi JI; Ode T; Hara-Yokoyama M
    Methods Mol Biol; 2018; 1804():401-410. PubMed ID: 29926420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis.
    Burger KN; van der Bijl P; van Meer G
    J Cell Biol; 1996 Apr; 133(1):15-28. PubMed ID: 8601603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosphingolipid synthesis is essential for MDCK cell differentiation.
    Pescio LG; Favale NO; Márquez MG; Sterin-Speziale NB
    Biochim Biophys Acta; 2012 Jun; 1821(6):884-94. PubMed ID: 22387616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.